Welcome!

News Feed Item

Lung Transplantation-Pipeline Insights, 2014



 

 

 

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Lung Transplantation-Pipeline Insights, 2014

https://www.reportbuyer.com/product/2278637/-Lung-Transplantation-Pipeline-Insights-2014.html

SUMMARY
DelveInsight's," Lung Transplantation-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Lung Transplantation. This report provides information on the therapeutic development based on the Lung Transplantation dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Lung Transplantation
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Lung Transplantation pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Lung Transplantation and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Lung Transplantation
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Lung Transplantation pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions
Table of Contents
- Lung Transplantation Overview
- Lung Transplantation Pipeline Therapeutics
- Lung Transplantation Therapeutics under Development by Companies
- Lung Transplantation Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Lung Transplantation Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Lung Transplantation Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Lung Transplantation Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Lung Transplantation – Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Lung Transplantation – Discontinued Products
- Lung Transplantation – Dormant Products
- Companies Involved in Therapeutics Development for Lung Transplantation
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Lung Transplantation, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Lung Transplantation Assessment by Monotherapy Products
- Lung Transplantation Assessment by Combination Products
- Lung Transplantation Assessment by Route of Administration
- Lung Transplantation Assessment by Stage and Route of Administration
- Lung Transplantation Assessment by Molecule Type
- Lung Transplantation Assessment by Stage and Molecule Type
- Lung Transplantation Therapeutics – Discontinued Products
- Lung Transplantation Therapeutics – Dormant Products
- Products under Development by Companies, 2014


List of Figures

- Number of Products under Development for Lung Transplantation, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Lung Transplantation Assessment by Monotherapy Products
- Lung Transplantation Assessment by Combination Products
- Lung Transplantation Assessment by Route of Administration
- Lung Transplantation Assessment by Stage and Route of Administration
- Lung Transplantation Assessment by Molecule Type
- Lung Transplantation Assessment by Stage and Molecule Type



Read the full report:
Lung Transplantation-Pipeline Insights, 2014

https://www.reportbuyer.com/product/2278637/-Lung-Transplantation-Pipeline-Insights-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SAP is the world leader in enterprise applications in terms of software and software-related service revenue. Based on market capitalization, we are the world's third largest independent software manufacturer. Harness the power of your data and accelerate trusted outcome-driven innovation by developing intelligent and live solutions for real-time decisions and actions on a single data copy. Support next-generation transactional and analytical processing with a broad set of advanced analytics - r...
DXWorldEXPO LLC announced today that Kevin Jackson joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Kevin L. Jackson is a globally recognized cloud computing expert and Founder/Author of the award winning "Cloud Musings" blog. Mr. Jackson has also been recognized as a "Top 100 Cybersecurity Influencer and Brand" by Onalytica (2015), a Huffington Post "Top 100 Cloud Computing Experts on Twitter" (2013) and a "Top 50 C...
Provide an overview of the capabilities of Azure Stack allowing you or your customers to adopt truly consistent Hybrid Cloud capabilities to deliver greater productivity in your cloud world. Ultan Kinahan is on a member of the Global Black Belt team at Microsoft with a focus on Azure Stack Hybrid Cloud. Ultan has been in the Azure team since the beginning, Has held roles in Engineering, Sales and now consults with both small to medium size business and the worlds largest organizations on how to ...
As the fourth industrial revolution continues to march forward, key questions remain related to the protection of software, cloud, AI, and automation intellectual property. Recent developments in Supreme Court and lower court case law will be reviewed to explain the intricacies of what inventions are eligible for patent protection, how copyright law may be used to protect application programming interfaces (APIs), and the extent to which trademark and trade secret law may have expanded relev...
Early Bird Registration Discount Expires on August 31, 2018 Conference Registration Link ▸ HERE. Pick from all 200 sessions in all 10 tracks, plus 22 Keynotes & General Sessions! Lunch is served two days. EXPIRES AUGUST 31, 2018. Ticket prices: ($1,295-Aug 31) ($1,495-Oct 31) ($1,995-Nov 12) ($2,500-Walk-in)
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
Contino is a global technical consultancy that helps highly-regulated enterprises transform faster, modernizing their way of working through DevOps and cloud computing. They focus on building capability and assisting our clients to in-source strategic technology capability so they get to market quickly and build their own innovation engine.
Blockchain is a new buzzword that promises to revolutionize the way we manage data. If the data is stored in a blockchain there is no need for a middleman - the distributed database is stored on multiple and there is no need to have a centralized server that will ensure that the transactions can be trusted. The best way to understand how a blockchain works is to build one. During this presentation, we'll start with covering the basics (hash, nounce, block, smart contracts) and then we'll create ...
DevOpsSUMMIT at CloudEXPO will expand the DevOps community, enable a wide sharing of knowledge, and educate delegates and technology providers alike. Recent research has shown that DevOps dramatically reduces development time, the amount of enterprise IT professionals put out fires, and support time generally. Time spent on infrastructure development is significantly increased, and DevOps practitioners report more software releases and higher quality. Sponsors of DevOpsSUMMIT at CloudEXPO will b...
FinTech Is Now Part of the CloudEXPO New York Program. Financial enterprises in New York City, London, Singapore, and other world financial capitals are embracing a new generation of smart, automated FinTech that eliminates many cumbersome, slow, and expensive intermediate processes from their businesses. Accordingly, attendees at the upcoming 22nd CloudEXPO | DXWorldEXPO November 12-13, 2018 in New York City will find fresh new content in two new tracks called: FinTechEXPO New York Blockchain E...
In addition to 22 Keynotes and General Sessions, pick from 40 technical sessions in two tracks: (1) DevOpsSUMMIT (2) Cloud-Native & Serverless. EXPIRES AUGUST 31, 2018. Ticket prices: ($295-Aug 31) ($395-Oct 31) ($495-Nov 12) ($595-Walk-in) Does NOT include lunch. DevOps Institue Certification DevOps Institute Two-Day DevOps Certification Program EXPIRES AUGUST 31, 2018. Ticket prices: ($995-Aug 31) ($1,095-Oct 31) ($1,195-Nov 12) ($1,395-Walk-in)
Cloud adoption is a core component of digital transformation. Scaling the IT environment, making it resilient, and reducing costs are what organizations want. Hear from the author of the best selling Packtbook "Architecting Cloud Computing Solutions" as he presents and explains critical Cloud solution design considerations and technology decisions required to choose and deploy the right Cloud service and deployment models, that are aligned to your business and technology service requirements. T...
Wasabi is the hot cloud storage company delivering low-cost, fast, and reliable cloud storage. Wasabi is 80% cheaper and 6x faster than Amazon S3, with 100% data immutability protection and no data egress fees. Created by Carbonite co-founders and cloud storage pioneers David Friend and Jeff Flowers, Wasabi is on a mission to commoditize the storage industry. Wasabi is a privately held company based in Boston, MA. Follow and connect with Wasabi on Twitter, Facebook, Instagram and the Wasabi blog...
Today we introduced our New York & Silicon Valley combo sponsorship and exhibit opportunities with unmatched pre and post-show promotion. At CloudEXPO | DevOpsSUMMIT | DXWorldEXPO NY & CA, Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune...
Addteq is a leader in providing business solutions to Enterprise clients. Addteq has been in the business for more than 10 years. Through the use of DevOps automation, Addteq strives on creating innovative solutions to solve business processes. Clients depend on Addteq to modernize the software delivery process by providing Atlassian solutions, create custom add-ons, conduct training, offer hosting, perform DevOps services, and provide overall support services.